14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $27.14 $35.40 Friday, 3rd May 2024 AGIO stock ended at $34.54. This is 0.116% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.26% from a day low at $33.63 to a day high of $35.40.
90 days $22.41 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Mar 30, 2023 $23.26 $23.57 $22.53 $22.55 572 445
Mar 29, 2023 $22.76 $23.53 $22.63 $23.13 446 665
Mar 28, 2023 $22.21 $22.81 $22.21 $22.55 730 995
Mar 27, 2023 $22.19 $22.36 $21.89 $22.25 451 750
Mar 24, 2023 $21.76 $21.94 $21.07 $21.74 603 436
Mar 23, 2023 $22.10 $22.39 $21.39 $21.98 434 114
Mar 22, 2023 $23.00 $23.05 $21.79 $21.79 453 585
Mar 21, 2023 $22.85 $23.35 $22.66 $23.12 379 618
Mar 20, 2023 $23.22 $23.26 $22.44 $22.73 457 191
Mar 17, 2023 $23.89 $23.89 $22.99 $23.26 796 419
Mar 16, 2023 $23.36 $24.37 $23.12 $24.00 614 377
Mar 15, 2023 $22.36 $23.84 $22.36 $23.63 662 937
Mar 14, 2023 $23.20 $23.45 $22.49 $22.85 600 823
Mar 13, 2023 $21.67 $23.01 $21.66 $22.62 757 007
Mar 10, 2023 $22.48 $22.48 $21.12 $21.97 859 855
Mar 09, 2023 $23.54 $23.54 $22.32 $22.60 520 355
Mar 08, 2023 $23.51 $23.77 $22.96 $23.54 433 564
Mar 07, 2023 $23.99 $24.35 $23.53 $23.56 481 892
Mar 06, 2023 $25.14 $25.14 $23.69 $24.17 481 154
Mar 03, 2023 $24.29 $24.72 $24.02 $24.44 416 647
Mar 02, 2023 $24.78 $25.07 $24.18 $24.20 671 303
Mar 01, 2023 $25.21 $25.79 $24.70 $25.01 647 610
Feb 28, 2023 $25.25 $26.13 $25.15 $25.31 733 756
Feb 27, 2023 $25.41 $25.92 $25.11 $25.26 604 012
Feb 24, 2023 $25.61 $25.89 $25.03 $25.11 584 000
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT